Atlas Trials

Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment

Clinical trial NCT02365402 · UNKNOWN

Trial details

NCT number
NCT02365402
Sponsor
Beijing Ditan Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis B
Start date
2013-01-01
Primary completion
2016-12-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.